ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
6,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,3,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
7,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
7,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
8,1,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
9,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
10,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
10,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
11,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
13,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
13,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
14,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
14,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
15,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
16,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
16,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
17,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
17,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
17,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
18,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
19,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
19,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
19,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
20,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
20,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
20,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
21,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
21,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
22,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
24,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
24,2,Myopathy,Myopathies,Muscle disorders,Musc,N
24,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
25,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
26,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
26,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
27,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
28,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
28,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
28,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
28,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
28,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
29,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
29,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
30,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
30,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
31,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
32,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
32,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
32,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
33,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
35,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
36,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
36,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
36,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
37,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
38,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
38,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
38,3,Primary amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
38,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
39,2,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
40,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
41,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
42,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
42,2,Headache,Headaches NEC,Headaches,Nerv,N
42,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
42,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
43,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
43,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
44,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
45,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
45,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
45,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
45,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
45,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
45,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
45,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
46,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
46,3,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
46,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
46,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
47,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
48,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
48,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
49,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
49,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
49,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
50,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
51,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
51,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
52,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
53,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
53,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
54,2,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
54,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
55,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
56,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
56,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
57,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
57,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
57,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,1,Vasculitic ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
60,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
60,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
61,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
61,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
62,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
63,1,Cellulitis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
63,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
63,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
63,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
63,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
63,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
63,8,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
63,9,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
63,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
63,12,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
63,13,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
64,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
65,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
66,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
66,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
67,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
68,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
69,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
70,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
71,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
71,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
71,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
71,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
71,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
72,1,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
72,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
72,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
73,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
74,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
75,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
75,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
76,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
77,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
78,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
79,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
79,3,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
80,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
81,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
81,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
81,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
81,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
81,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,10,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
81,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
81,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
83,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
83,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
84,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
87,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
87,2,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
88,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
88,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
88,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
89,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
90,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
90,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
90,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
90,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
90,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
90,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
90,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
91,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
91,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
91,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
91,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
92,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
92,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
92,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,5,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,6,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
93,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
93,2,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
94,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
94,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
95,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
95,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
95,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
96,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
96,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
96,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
97,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
98,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
98,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
99,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
101,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
102,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
102,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
104,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
104,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
105,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
105,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
106,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
107,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
107,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
107,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
108,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
109,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
110,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
111,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
112,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
113,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
113,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
113,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
113,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
114,2,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
115,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
115,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,3,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
115,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
116,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
117,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
117,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
117,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
118,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
118,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
118,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
118,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,5,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
118,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
118,8,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
120,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
120,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
120,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
120,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
121,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
122,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
122,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
124,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
125,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
125,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
126,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
127,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
129,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
130,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
130,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
130,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
130,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
131,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
132,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
132,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
132,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
132,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
133,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
133,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
133,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
134,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
134,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
134,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
134,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
135,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
135,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
135,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,6,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
135,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
136,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
137,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
137,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
138,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
139,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
140,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
140,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
140,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
140,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
141,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
142,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
143,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
144,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
144,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
144,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
145,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
145,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
145,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
146,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
146,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
147,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
148,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
149,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
150,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
151,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
151,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
152,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
153,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
154,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
155,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
156,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
157,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
158,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
158,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
159,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
159,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
159,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
160,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
160,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
161,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
163,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
164,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
165,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
167,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
168,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
170,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
171,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
172,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
173,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
173,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
174,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
174,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
174,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
175,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
175,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
175,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
175,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
175,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
175,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
175,7,Sitting disability,Disability issues,Lifestyle issues,SocCi,N
176,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
176,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
177,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
177,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
178,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
178,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
179,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
180,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
180,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
180,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
180,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
181,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
182,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
182,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
182,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
183,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
184,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
185,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
186,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
187,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
188,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
189,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
189,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
190,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
191,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
192,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
193,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
194,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
195,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
196,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
197,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
198,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
198,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
198,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
199,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
199,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
200,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
201,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
201,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
203,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
205,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
206,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
206,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
207,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
207,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
207,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
208,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
209,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
210,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
210,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
211,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
211,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
211,3,Red blood cell count abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
211,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
212,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
212,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
213,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
213,2,Headache,Headaches NEC,Headaches,Nerv,N
214,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
214,2,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
215,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
215,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
216,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
216,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
217,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
217,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
217,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
218,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
219,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
